Sign in 
SUBSCRIBE

  • Home
  • Pricing Policies

Pricing Policies

dummy-img
Biopharma

How Will Emerging Drug Pricing…

ByByAnuja Singh Mar 6, 2026
Image Not Found
Image Not Found

Tags

Gallery

Can Novo Nordisk’s AI Partnership with AWS Transform the Drug Discovery Timeline?
OmniAb and Eli Lilly Announce $370M Global Collaboration to Discover Antibody-Based Therapeutics Targeting Ion Channels
Sandoz’s $314M Bet on Chinese Biosimilars Targets a Drug the Industry Couldn’t Crack for a Decade
Merck and Moderna’s Melanoma Vaccine Win Could Be the Proof Point mRNA Oncology Has Been Waiting For
Prosper Medical’s $16M Raise Is a Bet That AI Can Make Concierge Medicine Affordable — Not Just Convenient
The FDA Just Created a Reimbursement Pathway for AI-Driven Care — Here’s Why That Matters More Than the Device, Dexcom the first participant in its TEMPO pilot.
GSK Bets on Cambridge: Inside the R&D Push Behind a £40 Billion Sales Target
Most-Favored-Nation Pricing: How U.S. Drug Prices Are Being Reset
Inside Medicare’s First Price Cuts: What a 38–79% Discount on 10 Blockbuster Drugs Means for Biopharma’s Next Decade
Scroll to Top